Search

Author/Creator Otterson, Daniel

2. Real‐world experience in treating pediatric relapsed/refractory or therapy‐related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Issue 10 (21st June 2022)

Authors:
Schafer, Eric S.; Chao, Karen; Stevens, Alexandra M.; Jo, Eunji; Hilsenbeck, Susan G.; Gossai, Nathan P.; Doan, Andrew; Colace, Susan I.; Guinipero, Terri; Otterson, Daniel; Kaplan, Joel A.; Hinson, Ashley; Pommert, Lauren; Wayne, Alan S.; Bhojwani, Deepa; Burke, Michael J.
Journal:
Pediatric blood & cancer
Issue:
Volume 69:Issue 10(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗